Fortress Biotech, Inc.FBIONASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank43
3Y CAGR-37.3%
5Y CAGR-28.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-37.3%/yr
vs +35.3%/yr prior
5Y CAGR
-28.2%/yr
Recent deceleration
Acceleration
-72.6pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.73 | +153.2% |
| 2023 | 0.29 | -62.7% |
| 2022 | 0.77 | -73.9% |
| 2021 | 2.97 | -40.7% |
| 2020 | 5.01 | +30.4% |
| 2019 | 3.84 | +176.1% |
| 2018 | 1.39 | +56.9% |
| 2017 | 0.89 | -86.5% |
| 2016 | 6.55 | -94.8% |
| 2015 | 126.56 | - |